MSK Flashcards
Define Osteoarthiritis
Non inflammatory degenerative arthiritis resulting in loss of perarticular cartilage
Osteoarthiritis epidemiology
- Affects who?
-Primary
Secondary
- Most common arthiritis WW
- Affects >60 y/o
- Primary - Generalised
- Secondary - joint disease, heamochromatosis and obesity
Osteoarthiritis RF
Age Female Genetics obesity fracture through joint occupation - farming (hip) football (knees) pre existing joint damage
Osteoarthirtis patho
- Imbalance or damage and repair process
cartilage undergoes erosion - disordered attempt at repair by chondrocytes
Exposed bone becomes sclerotic
-Increased vascularity and subchondral cyst formation - exposed bone grows outwards and forms osteophytes
Osteoarthiritis CP
symptoms
signs
sx - - Morning stiffnes <30mins - Pain (ache) exaccerbated by movement pain at rest in severe OA - reduced functionality -Stiffness after rest
signs - - Crepitus -Herbeden nodes -Bouchard nodes -joint deformity -muscle wasting limited joint movement
OA common joints affected
PIP DIP MCP Metatarsalphalangeal joints hips knees vertebrae
OA investigations
X-ray L - loss of joint space O - Osteophytes S - Subchondral sclerosis S -Sucbchondral cysts
FBC - CRP slightly elevated
Dx OA
activity related joint pain
<30 mins morning stiffness
X-ray
Tx OA
core
non pharm
pharm
core -
- excercise - increase locaal muscle strength
- Loose weight if obese
Non pharm - - acupuncture - knee - joint support footwear w/ shock absorbing properties -Stretching -physio
Pharm -
1. paracetmaol + topical NSAIDs
If inneffective add Oral NSAIDs and PPI
- Codeine
- Intra- articular steroid injection
temp pain relief in severe sx - surgery
joint replacement
DD and complications OA
comp - reduced mobility
DD -
R.A
Psoriatic arthiritis
Define R.A
Chronic systemic AI inflammatory disorder resulting in symmetrical polyarthritis
R.A epidemiology
- gender
- peak onset
- associations
F>M
50-60 y/o
HLA-DR1/4 assosciations - with severity
R.A Aetiolgy
- Family hx
- Gender - increase incidence in premenopausal women
- HLA-DR4 and HLA-DRB1 confers suceptibilty to R.A
- smoking
R.A patho
-infliltration of synovium ny IC –> synovitis
-angiogenic cytokines result in new synovial blood vessel formation
-synovium proliferates and grows over surface of bone producing pannus
-pannus destroys cartilage and bone
cartilage thins leading to bony erosions and lesions
R.A CP
sx
signs
sx -
- Painful joints - multiple
- Morning stifness >30mins
- symetrical swelling
- Pain eases with use
signs
- ulnar deviation
- boutonniere defromity
- swan neck deformity
- z shaped thumb defromity
- joints - warm, tender, swollen
- muscle wasting
- joint sublaxation
- rheumatoid nodules
- carpal tunnel syndrome
R.A extra articular manifestations
lung
- interstital lung fibrosis
- pleural effusions
cardio
- IHD (increased risk of atheroma formation)
- pericarditis
- pericardial effusions
skin
- rhematoid nodules
- Raynauds
- Carpal tunnel
eyes
- scleritis
- sjrogens syndorme
systemic:
fever
fatigue
weight loss
R.A common joints
- MCP
- PIP
- MTP
R.A Investigations
investigations
- Rheumatoid Factor –> not specific
-Anti- cyclic citrullinated peptide (Anti - CCP)
very specific
marker of disease
+ve–> worse prognosis
-FBC - normocytic anaemia
thrombocytosis
raised CRP+ESR
-X-ray L - Loss of joint space E - peri-articular erosions S - soft tissue sewlling S- soft bones - osteopenia
R.A tx
smoking cessation - decrease c.v risk
physiotherapy
excercise
disease activity monitered by DAS28
1 . NSAIDs - relieve joint pain and stiffness
- Paracetamol and codeine - additional pain relief
- corticosteroids
useful for acute flares
suppress disease activity but large doses required–> toxicity
- IM methylprednisolone
depot for those waiting for DMARDs - contols severe flares - DMARDs
- inhibit inflamm cytokines so reduce disease progression and joint errosion
INFECTION RISK
- early use impoves long term outcomes (started within 3m of persistent sx)
-6 weeks before effects
DMARDs name and S/E
Methotrexate CI - Pregnancy S/E - mouth ulcers tetarogenic Diarrhoea renal impairment
Sulfasalazine - modertae disease used in young women S/E: nausea rash mouth ulcers GI upset male infertility
Leflunomide blocks t cell proliferation s/e: tetarogenic oral ulcers heaptotoxicity
TNF-aplha inhibitors –> Infliximab
etanercept
adalimumab
O.P defintion
systemic skeletal disease charecterised by low bone mass leading to bone fragility and increase fracture risk
O.P primary and secondary
- age related and menopause
2. Drugs and another condition
What is PBM determined by
genetics
nutrition
physical activity
hormones
O.P risk factors and aetiology
Un-tx menopause Immobility Alcohol Inflammatory disease Cushings DM drugs - heparin smoking
S - Steroids H - Hyperparathyroid/Thyroid A - Alcohol T - Thin (low BMI) T - Testosterone low E - Early menopause R - Renal/Liver failure E - erosice bone disease - R.A D - Dietary low calcium